Login / Signup

Oral Agents and SARS-CoV-2 Vaccine Effectiveness Against Severe COVID-19 Omicron Events in Maintenance Dialysis Patients.

Harold J ManleyNien Chen LiCaroline M HsuDaniel E WeinerDana MiskulinAntonia M HarfordDoug JohnsonEduardo Lacson
Published in: Kidney360 (2024)
Keyphrases
  • sars cov
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • coronavirus disease
  • ejection fraction
  • newly diagnosed
  • randomized controlled trial
  • systematic review